ALFA FinderNSE filing, NSE: SAROJA. Summary written from the filing by ALFA Finder's alert engine.
Saroja Pharma Industries India Ltd: key numbers
- Share price
- ₹38.00
- Market cap
- ₹15.28 Cr
- Revenue (annual)
- ₹70.13 Cr
- Net profit (annual)
- ₹1.61 Cr
- P/E (TTM)
- 9.5×Sector 35.5×
- Promoter holding
- 73.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saroja Pharma Industries India Ltd
All →Saroja Pharma Industries India Management Change
Saroja Pharma's statutory auditor Pravin Chandak & Associates resigned effective October 26, 2026, citing pre-occupation. The company will appoint new auditors to fill the vacancy.
Saroja Pharma Industries India Management Change
Mr. Ravindra Shivaji Salaskar has resigned as Whole-time Director of Saroja Pharma Industries India Limited, effective October 5, 2026. He continues as the company's CFO.
Saroja Pharma Industries India Annual General Meeting
Saroja Pharma Industries India Limited held its 8th Annual General Meeting on September 30, 2026, through video conferencing to transact business.
Saroja Pharma Industries India Management Change
Saroja Pharma Industries India Limited appointed Mr. Ravindra Shivaji Salaskar as Chief Financial Officer. He currently serves as a Whole-time Director of the company.
Saroja Pharma Industries India Annual General Meeting
Saroja Pharma Industries India Limited has issued a notice for its 8th Annual General Meeting, scheduled to be held on September 30, 2026, through video conferencing.
Saroja Pharma Industries India Board Meeting Outcome
Saroja Pharma Industries approved its draft Board Report, Management Discussion and Analysis Report, and the notice for its 8th Annual General Meeting.
Other other announcement announcements
All →Triveni Glass Other Announcement
Triveni Glass director Anil Kumar Dhawan bought 15,188 shares on BSE for Rs.1,43,992. Routine PIT Reg 7(2) disclosure by a non-promoter director.
- Value
- ₹0.01 Cr
GRE Renew Enertech Other Announcement
GRE Renew Enertech filed its Reg 32 quarterly statement on IPO proceeds utilisation. It reports a reallocation of funds from solar plant capex to general corporate purposes.
Vectras Enprocon Other Announcement
Director Ravi P Patel bought 12,000 Vectras Enprocon shares for Rs. 0.13 Crore on BSE. No promoter involvement in this routine market purchase.
- Value
- ₹0.13 Cr
LGT Global Hospitality Other Announcement
LGT Global Hospitality filed its quarterly Monitoring Agency Report for Q1 FY27 under ICDR 162A. The report confirms Nil deviation in utilisation of its ₹21.92 crore IPO proceeds.
Astra Microwave Products Other Announcement
Astra Microwave filed a Reg 32 statement for the quarter ended September 30, 2026. It confirms no deviation or variation in the use of preferential-issue warrant proceeds.
Rane Holdings Other Announcement
Rane Holdings filed its Q1 FY27 Reg 32 statement on use of preferential-warrant proceeds. It reported ₹10 Cr raised and ₹7.81 Cr utilised for borrowings, with no deviation.